- $685.26m
- $678.76m
- $480.59m
Phreesia rises on upbeat forecast, results
U.S. RESEARCH ROUNDUP-Alignment Healthcare, Comerica, M&T Bank Corp
Phreesia Inc reports results for the quarter ended in July - Earnings Summary
Brief: Phreesia Announces Fiscal Second Quarter 2023 Results
Phreesia Inc expected to post a loss of 74 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Cooper Companies, Moody's, Seagen
U.S. RESEARCH ROUNDUP-Aeglea Bio Therapeutics, Ecolab, Martin Marietta Materials
Phreesia Inc expected to post a loss of 95 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Autonation, Group 1 Automotive, Vapotherm
U.S. RESEARCH ROUNDUP- Blend Labs, Unifirst, Vertiv Holdings
U.S. STOCKS ON THE MOVE-Baidu, Clarus, cruise operators
U.S. STOCKS ON THE MOVE-Datadog Inc, Expensify Inc, Walgreens
U.S. STOCKS ON THE MOVE-UiPath Inc, Tesla Inc, Oil firms
Phreesia drops on wider Q4 loss, analysts cut PTs
U.S. RESEARCH ROUNDUP- Codexis, Ionis Pharmaceuticals, Travere Therapeutics
Phreesia Inc reports results for the quarter ended in January - Earnings Summary
Brief: Phreesia Says On March 28, Entered Into First Loan Modification Agreement
Brief: Phreesia Announces Fiscal Year Ended January 31, 2022 Results
Phreesia Inc expected to post a loss of 85 cents a share - Earnings Preview